Are Markers of Inflammation More Strongly Associated with Risk for Fatal Than for Nonfatal Vascular Events?

Leptin and Coronary Heart Disease

(2009) Naveed Sattar et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

(2009) Paul M Ridker et al.   LANCET

Associations of plasma pro-inflammatory cytokines, fibrinogen, viscosity and C-reactive protein with cardiovascular risk factors and social deprivation: the fourth Glasgow MONICA study

(2008) Paul Welsh et al.   BRITISH JOURNAL OF HAEMATOLOGY

Novel antecedent plasma biomarkers of cardiovascular disease: improved evaluation methods and comparator benchmarks raise the bar

(2008) Paul Welsh et al.   CURRENT OPINION IN LIPIDOLOGY

Leptin Predicts Diabetes but Not Cardiovascular Disease: Results from a large prospective study in an elderly population

(2008) P. Welsh et al.   DIABETES CARE

Biomarkers of inflammation predict both vascular and non-vascular mortality in older men

(2008) Robert Clarke et al.   EUROPEAN HEART JOURNAL

Pioglitazone, a peroxisome proliferator-activated receptor-γ agonist, attenuates myocardial ischemia–reperfusion injury in mice with metabolic disorders

(2008) Tsuyoshi Honda et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies

(2008) Naveed Sattar et al.   LANCET

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial

(2008) Josef S Smolen et al.   LANCET

Use of Multiple Biomarkers to Improve the Prediction of Death from Cardiovascular Causes

(2008) Björn Zethelius et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-Term Interleukin-6 Levels and Subsequent Risk of Coronary Heart Disease: Two New Prospective Studies and a Systematic Review

(2008) John Danesh et al.   PLOS MEDICINE

C-Reactive Protein and All-Cause Mortality in a Large Hospital-Based Cohort

(2007) C. Marsik et al.   CLINICAL CHEMISTRY

Prospective Study of High-Sensitivity C-Reactive Protein as a Determinant of Mortality: Results from the MONICA/KORA Augsburg Cohort Study, 1984-1998

(2007) W. Koenig et al.   CLINICAL CHEMISTRY

Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology

(2007) Debbie A. Lawlor et al.   STATISTICS IN MEDICINE